Comparison of efficacy of intravenous and submucosal Dexamethasone in transalveolar extraction of mandibular third molar
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 200
- 试验地点
- 1
研究概览
简要总结
The removal of lower third molars is the most common surgical procedure done by oral and maxillo facial surgeons. It is often associated with swelling, pain and trismus as a result of the postoperative inflammatory response, and these can have a serious impact on the patient’s quality of life, as well as having financial consequences*.*When body tissues are injured the normal physiologic response is inflammation and pain to varying degree. Inflammation occurs after every surgical intervention and should be expected. The most important component of inflammation is vasodilation, which allows cells and mediators entry to the affected area; these are responsible for neutralizing and removing the antigens and the remains of damaged tissue.Corticosteroids are often used to minimize the post-operative inflammation following surgical removal of mandibular third molar . Mechanism of action of corticosteroid includes inhibition of the enzyme phospholipase A2 , which inhibits the conversion of phospholipids into arachidonic acid in the cells of the inflamed focus. This will decrease prostaglandin and leukotriene synthesis, therefore reducing the accumulation of neutrophils and thereby reducing inflammation. Dexamethasone , with its long half-life, potency, and almost pure glucocorticoid activity makes it a safe and effective anti-infammatory drug . Dexamethasone is usually administered via various routes like Intravenous, Intramuscular and Oral.
研究设计
- 研究类型
- Interventional
- 分配方式
- Coin toss, Lottery, toss of dice, shuffling cards etc
- 盲法
- Participant Blinded
入排标准
- 年龄范围
- 21.00 Day(s) 至 50.00 Year(s)(—)
- 性别
- All
入选标准
- •Partially or fully impacted mandibular third molar that requires surgical extraction.
- •Root formation should be complete.
- •Age 21-50 years.
- •Only ASA Class I of physical status classification.
排除标准
- •1.Patient with immunocomprosised disease.
- •2.Periodonatally compromised posterior teeth.
- •3.Pregnancy and lactation.
- •4.ASA Class II of systemic classification and above.
- •5.Age less than 21 or more than 51.
研究者
Ratna More
Government Dental College and Hospital
